Sees Q1 reported revenue growth in the high single digits, with organic revenue at or above the 10% level y/y, consensus $981.09M. Expects stronger revenue growth rates in 1H23 due to the comparison to FY22 when the growth rate accelerated throughout the year and the gating of NHP supply impact; Only expect small impact related to NHP supply in 1Q23.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CRL:
- Charles River Plunges after Monkey Troubles Set In
- Charles River acquires SAMDI Tech for $50M cash
- iVexSol closes $23.8M Series A-3 financing
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Charles River establishes eXpDNA plasmid manufacturing platform
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue